Known targets — ChEMBL curated mechanism
ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Acetic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | GSR | P00390 | 1/20 | 0.41 |
| ▸ | CPB2 | Q96IY4 | 2/20 | 0.38 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.35 |
| ▸ | DPP4 | P27487 | 1/20 | 0.35 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.35 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.35 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.35 |
| ▸ | GABRR1 | P24046 | 2/20 | 0.34 |
| ▸ | PAOX | Q6QHF9 | 1/20 | 0.34 |
| ▸ | ENPEP | Q07075 | 2/20 | 0.34 |
| ▸ | S1PR2 | O95136 | 5/20 | 0.34 |
| ▸ | S1PR1 | P21453 | 5/20 | 0.34 |
| ▸ | S1PR3 | Q99500 | 5/20 | 0.34 |
| ▸ | S1PR4 | O95977 | 4/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetic Acid SCHEMBL28621822 | 1.00 | ALDH1A1 (0.43) | ALDH1A1GSRCPB2RNPEPDPP4 | |
| Acetic Acid SCHEMBL19582076 | 0.92 | GSR (0.46) | ALDH1A1GSRCPB2RNPEPGABRR1 | |
| Acetic Acid SCHEMBL28577417 | 0.92 | GSR (0.46) | ALDH1A1GSRCPB2RNPEPGABRR1 | |
| Acetic Acid SCHEMBL28575574 | 0.88 | ALDH1A1 (0.56) | ALDH1A1GSRCPB2RNPEPDPP4 | |
| Carbamic Acid SCHEMBL9873456 | 0.88 | GSR (0.43) | ALDH1A1GSRCPB2RNPEPDPP4 | |
| SCHEMBL30996125 | 0.87 | DNM1 (0.33) | ALDH1A1S1PR2S1PR1S1PR3S1PR4 | |
| SCHEMBL30529071 | 0.87 | DNM1 (0.33) | ALDH1A1S1PR2S1PR1S1PR3S1PR4 | |
| SCHEMBL29734738 | 0.87 | DNM1 (0.33) | ALDH1A1S1PR2S1PR1S1PR3S1PR4 | |
| Acetic Acid SCHEMBL28593370 | 0.86 | ALDH1A1 (0.55) | ALDH1A1GSRCPB2RNPEPDPP4 | |
| SCHEMBL18087875 | 0.82 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118541171-A | FAP-targeted pharmaceutical products for cancer treatment and diagnosis | 原子治疗有限公司 | 2024-08-23 | — | — | CN | claimed |
| EP-4281119-A1 | PRECURSOR MARKER AND RADIOTRACER FOR NUCLEAR-MEDICAL DIAGNOSIS AND THERAPY OF BONE-METASTATIC PROSTATE CANCER | SCV - SpezialChemikalienVertrieb GmbH (DE) | 2023-11-29 | — | — | EP | claimed |
| CN-114980931-A | Intelligent drug delivery system and kit for nuclear medicine cytotoxicity dual therapy diagnosis | SCV-特种化学品销售有限公司 | 2022-08-30 | — | — | CN | claimed |
| WO-2022157277-A1 | PRECURSOR MARKER AND RADIOTRACER FOR NUCLEAR-MEDICAL DIAGNOSIS AND THERAPY OF BONE-METASTATIC PROSTATE CANCER | SCV - SpezialChemikalienVertrieb GmbH (DE) | 2022-07-28 | — | — | WO | claimed |
| CN-113164630-A | Mark precursors with squaric acid linkage | SCV-特种化学品销售有限公司 | 2021-07-23 | — | — | CN | claimed |
| CN-107106711-B | Conjugated bisphosphonates for diagnosis and treatment of bone disease | SCV公司 | 2021-06-18 | — | — | CN | claimed |
| CN-118541171-A | FAP-targeted pharmaceutical products for cancer treatment and diagnosis | 原子治疗有限公司 | 2024-08-23 | — | — | CN | disclosed |
| CN-114980931-A | Intelligent drug delivery system and kit for nuclear medicine cytotoxicity dual therapy diagnosis | SCV-特种化学品销售有限公司 | 2022-08-30 | — | — | CN | disclosed |
| CN-114796533-A | Mark precursors with squaric acid linkage | SCV-特种化学品销售有限公司 | 2022-07-29 | — | — | CN | disclosed |
| CN-113164630-A | Mark precursors with squaric acid linkage | SCV-特种化学品销售有限公司 | 2021-07-23 | — | — | CN | disclosed |
| CN-107106711-B | Conjugated bisphosphonates for diagnosis and treatment of bone disease | SCV公司 | 2021-06-18 | — | — | CN | disclosed |